文献速递前列腺癌

密歇根州多元泌尿外科实践中前列腺癌风险计算器用于共享决策的评估

Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan.
PubMed 文献 · Urology · 2017-02-22

研究基于密歇根泌尿外科手术改进协作组(MUSIC)2012年1月至2015年3月全部首次前列腺穿刺活检数据,构建多分类逻辑回归模型预测高级别癌、低级别癌或无癌,并与PCPT风险计算器2.0版比较。MUSIC模型与PCPT计算器的区分度相当(多分类曲线下面积0.63 vs 0.62),但MUSIC模型校准更准确,PCPT计算器明显高估无癌可能性并低估高级别癌风险。

要点

  • MUSIC模型与PCPT计算器区分度相当,多分类曲线下面积分别为0.63和0.62。
  • PCPT计算器明显高估无癌可能性并低估高级别癌风险。
  • PCPT风险计算器可能不是当代泌尿外科实践患者个体活检结局的良好预测工具。

核心结论

  • PCPT风险计算器可能不是当代泌尿外科实践中所见患者个体活检结局的良好预测工具。

研究设计与样本

  • 基于MUSIC协作组2012年1月至2015年3月全部首次前列腺穿刺活检数据,构建多分类逻辑回归模型,并用10折交叉验证在样本外数据中评估。
  • 共纳入11809例活检,其中4289例(36.3%)为高级别癌,2027例(17.2%)为低级别癌,其余5493例(46.5%)为阴性。

主要发现

  • MUSIC模型中,前列腺特异性抗原水平、直肠指检发现、年龄、种族和前列腺癌家族史是穿刺发现高级别癌的显著预测因素。
  • 两模型基于相似预测因素,区分度相当:MUSIC模型多分类曲线下面积为0.63,PCPT计算器为0.62。
  • 校准分析显示MUSIC模型更准确地预测观察结局,而PCPT风险计算器在该人群中明显高估无癌可能性并低估高级别癌风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the predictive performance of a logistic regression model developed with contemporary data from a diverse group of urology practices to that of the Prostate Cancer Prevention Trial (PCPT) Risk Calculator version 2.0. MATERIALS AND METHODS: With data from all first-time prostate biopsies performed between January 2012 and March 2015 across the Michigan Urological Surgery Improvement Collaborative (MUSIC), we developed a multinomial logistic regression model to predict the likelihood of finding high-grade cancer (Gleason score ≥7), low-grade cancer (Gleason score ≤6), or no cancer on prostate biopsy. The performance of the MUSIC model was evaluated in out-of-sample data using 10-fold cross-validation. Discrimination and calibration statistics were used to compare the performance of the MUSIC model to that of the PCPT risk calculator in the MUSIC cohort. RESULTS: Of the 11,809 biopsies included, 4289 (36.3%) revealed high-grade cancer; 2027 (17.2%) revealed low-grade cancer; and the remaining 5493 (46.5%) were negative. In the MUSIC model, prostate-specific antigen level, rectal examination findings, age, race, and family history of prostate cancer were significant predictors of finding high-grade cancer on biopsy. The 2 models, based on similar predictors, had comparable discrimination (multiclass area under the curve = 0.63 for the MUSIC model and 0.62 for the PCPT calculator). Calibration analyses demonstrated that the MUSIC model more accurately predicted observed outcomes, whereas the PCPT risk calculator substantively overestimated the likelihood of finding no cancer while underestimating the risk of high-grade cancer in this population. CONCLUSION: The PCPT risk calculator may not be a good predictor of individual biopsy outcomes for patients seen in contemporary urology practices.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Auffenberg GB, Merdan S, Miller DC, et al. Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan. Urology. 2017. PMID: 28237530. doi:10.1016/j.urology.2017.01.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。